Drug intelligence / Profile preview

Insulin-like growth factor II

Development stage
Preclinical
Modality
Recombinant Proteins and Enzymes
Administration
Oral, Subcutaneous, Intravenous
01

Overview

Insulin-like growth factor II (IGF-II) is a peptide hormone and growth factor that plays a crucial role in growth and development. It is involved in various biological processes, including cell proliferation, metabolism, and angiogenesis. Aberrant secretion of IGF-II by tumors can lead to paraneoplastic hypoglycemia, a rare but serious condition. IGF-II also interacts with its receptor, IGF2R, and is implicated in processes like endoplasmic reticulum (ER) stress in chronic pain and hypoxia adaptability. Furthermore, its mRNA-binding proteins (IGF2BPs/IMP3) are significant in tumor metabolic reprogramming and progression in various cancers, including colorectal, cervical, and bladder cancers. Therapeutic strategies involving IGF2 biologics and IGF2-expressing exosomes are being explored for conditions like chronic postsurgical pain and critical limb ischemia, respectively. Its gene expression is also modulated in aquaculture to enhance growth performance in species like red tilapia and shrimp.

Other names
IGF2IGF-2IGF 2insulin-like growth factor IIIGF-II
02

Targets

IGF-1R (Insulin-like growth factor 1 receptor)IR-A (Insulin receptor isoform A)IGF2R (Cation-independent mannose-6-phosphate receptor)

Beyond the preview

Go deeper on Insulin-like growth factor II.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Insulin-like growth factor II.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call